Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
British energy giant BP Plc’s (BP - Analyst Report) offshore Egyptian gas development – Seth – produced its first gas more than three months before schedule. Italy’s Eni SpA (E - Analyst Report) has a 50% interest in the Seth structure through its subsidiary International Egyptian Oil Company.
The $334 million project lies 60 kilometer offshore in the Ras El Bar concession in the East Nile Delta Mediterranean. It is in the vicinity of the existing fields –– Ha'py and Denise.
Seth is being prepared with a 6 well slot, usually unmanned platform. The gas is expected to be delivered to El Gamil gas terminal by means of the Denise pipeline. The first two wells accessing the western part of the Seth reservoir are estimated to yield 170 million cubic feet per day (MMcf/d) and excavate around 240 billion cubic feet of gas.
The success achieved by BP in the Seth structure propelled the company to speed up Phase 2 development. Two additional platform wells are intended to be used by the company to attain gas in the eastern part of the field. The output at Seth is projected to grow over 250 MMcf/d, once the wells are commissioned by the end of 2012, as scheduled.
Till date, BP’s unit in Egypt, BP Egypt, in partnership with the Gulf of Suez Petroleum Company –– BP’s joint venture company with the Egyptian General Petroleum Company –– has produced around 40% of Egypt’s total oil output. Currently, BP Egypt yields about 15% of Egypt’s total oil production.
The exploration activities in the Mediterranean offer the company new prospects with high potential, as these deepwater regions remain mostly unexplored. The West Nile Delta project deserves a special mention here, as it will provide vital gas to the local markets and help in production growth from the ongoing discoveries.
BP holds a Zacks #3 Rank, which is equivalent to a Hold rating for a period of one to three months. Longer term, we maintain a Neutral recommendation on the stock.
Get the full Analyst Report on BP - FREE
Get the full Analyst Report on E - FREE